Brief: Active Biotech Q4 Operating Loss SEK 9.1 Million

Active Biotech AB publ

12/02/2026 07:53

Feb 12 (Reuters) - Active Biotech AB publ ACTI.ST:

Q4 EPS SEK -0.01

Q4 OPERATING PROFIT SEK -9.1 MILLION

Q4 CASH FLOW SEK 37.7 MILLION

Source text: ID:nMFN8mTZRy

Further company coverage: ACTI.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))